Status:

COMPLETED

A Research Study to Evaluate the Safety of R306465, a Drug in Development for Cancer and to Study the Absorption, Break Down and Elimination in Patients With Advanced Solid Malignancies.

Lead Sponsor:

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Collaborating Sponsors:

Janssen-Cilag Ltd.

Conditions:

Neoplasms

Eligibility:

All Genders

18+ years

Phase:

PHASE1

Brief Summary

The purpose of this study is to assess the safety of R306465 (a drug in development for cancer) in patients with advanced cancer on the maximum dose that can be tolerated. Also, the absorption, breakd...

Detailed Description

R306465, a histone deacetylase (HDAC) inhibitor, is a new drug in development for cancer. In this study, the safety (the effect on the body) of R306465 in patients with advanced cancer will be studied...

Eligibility Criteria

Inclusion

  • Confirmed solid malignancy that is metastatic or unresectable, and for which standard curative or palliative measures does not exist or are no longer effective
  • Performance status (based on the Eastern Cooperative Oncology Group assessments) of \<= 2
  • Life expectancy \> 3 months
  • Adequate gastrointestinal absorption status
  • Must meet protocol-defined criteria for lab assessments and adequate bone marrow, liver, and kidney function.

Exclusion

  • Known central nervous system metastases
  • Chemotherapy, radiotherapy, immunotherapy within 4 weeks before study drug administration or incomplete recovery from preceding surgery
  • Previous participation in a clinical study with histone deacetylase (HDAC) inhibitor or another investigational anticancer agent within 4 weeks of dosing with R306465
  • Patient has signs and symptoms of acute infection requiring systemic therapy
  • Patient is not recovered from reversible toxicity of prior anticancer therapy.

Key Trial Info

Start Date :

September 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2006

Estimated Enrollment :

15 Patients enrolled

Trial Details

Trial ID

NCT00677001

Start Date

September 1 2005

End Date

October 1 2006

Last Update

April 27 2010

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.